Guttate Leukoderma

  • Nisansala Mahenthi Nagodavithana
  • Prasad Kumarasinghe
Part of the Updates in Clinical Dermatology book series (UCD)


Guttate leukoderma refers to raindrop-like hypo- or depigmentation. It could result from a wide range of etiologies. A careful history and examination often provide the clues to the diagnosis.

The age of the patient is also important for the diagnosis. Some of the hereditary causes tend to manifest in the childhood. However, some acquired causes such as pityriasis alba, achromic verruca plana, and pityriasis lichenoides chronica also occur predominantly in children. On the contrary, conditions like idiopathic guttate hypomelanosis preferentially affect the elderly.

This chapter mainly focuses on the commonest cause of guttate leukoderma, idiopathic guttate hypomelanosis (IGH). In addition, we discuss the clinical features and some important aspects of other causes for guttate leukoderma.


Guttate leukoderma Guttate hypomelanosis Guttate hypochromia Idiopathic guttate hypomelanosis (IGH) 


  1. 1.
    Cummings KI, Cottel WI. Idiopathic guttate hypomelanosis. Arch Dermatol. 1966;93(2):184–6.CrossRefGoogle Scholar
  2. 2.
    Costa OG. Progressive symmetrical leukopathia of the extremities. Ann Dermatol Syphiligr (Paris). 1951;78(4):452–4.Google Scholar
  3. 3.
    Whitehead WJ, Moyer DG, Vander Ploeg DE. Idiopathic guttate hypomelanosis. Arch Dermatol. 1966;94(3):279–81.CrossRefGoogle Scholar
  4. 4.
    Hamada T, Saito T. Senile depigmented spots (idiopathic guttate hypomelanosis) . Arch Dermatol. 1967;95(665).Google Scholar
  5. 5.
    Shin MK, Jeong KH, Oh IH, Choe BK, Lee MH. Clinical features of idiopathic guttate hypomelanosis in 646 subjects and association with other aspects of photoaging. Int J Dermatol. 2011;50(7):798–805.CrossRefGoogle Scholar
  6. 6.
    Falabella R, Escobar C, Giraldo N, Rovetto P, Gil J, Barona MI, et al. On the pathogenesis of idiopathic guttate hypomelanosis. J Am Acad Dermatol. 1987;16(1 Pt 1):35–44.CrossRefGoogle Scholar
  7. 7.
    Kim SK, Kim EH, Kang HY, Lee ES, Sohn S, Kim YC. Comprehensive understanding of idiopathic guttate hypomelanosis: clinical and histopathological correlation. Int J Dermatol. 2010;49(2):162–6.CrossRefGoogle Scholar
  8. 8.
    Arrunategui A, Trujillo RA, Marulanda MP, Sandoval F, Wagner A, Alzate A, et al. HLA-DQ3 is associated with idiopathic guttate hypomelanosis, whereas HLA-DR8 is not, in a group of renal transplant patients. Int J Dermatol. 2002;41(11):744–7.CrossRefGoogle Scholar
  9. 9.
    McDaniel WE, Richfield DF. Macular hypopigmentation on legs of women. Dermatol Digest. 1965;4:59–66.Google Scholar
  10. 10.
    Kumarasinghe P. Idiopathic guttate hypomelanosis. In: Dermatological cryosurgery and cryotherapy. London: Springer; 2016. p. 407–11.CrossRefGoogle Scholar
  11. 11.
    Juntongjin P, Laosakul K. Idiopathic guttate hypomelanosis: a review of its etiology, pathogenesis, findings, and treatments. Am J Clin Dermatol. 2016;17(4):403–11.CrossRefGoogle Scholar
  12. 12.
    Bambroo MP, Pande S, Khopkar U. Dermoscopy in the differentiation of idiopathic guttate hypomelanosis (IGH) and Guttate vitiligo. In: Khopkar S, editor. Dermoscopy and trichoscopy in diseases of the brown skin atlas and short text. 1st ed. New Delhi: Jaypee Brothers Ltd; 2012. p. 97–103.CrossRefGoogle Scholar
  13. 13.
    Ankad BS, Beergouder SL. Dermoscopic evaluation of idiopathic guttate hypomelanosis: a preliminary observation. Indian Dermatol Online J. 2015;6(3):164–7.CrossRefGoogle Scholar
  14. 14.
    Joshi R. Skip areas of retained melanin: a clue to the histopathological diagnosis of idiopathic guttate hypomelanosis. Indian J Dermatol. 2014;59(6):571–4.CrossRefGoogle Scholar
  15. 15.
    Wilson PD, Lavker RM, Kligman AM. On the nature of idiopathic guttate hypomelanosis. Acta Derm Venereol. 1982;62(4):301–6.PubMedGoogle Scholar
  16. 16.
    Kakepis M, Havaki S, Katoulis A, Katsambas A, Stavrianeas N, Troupis TG. Idiopathic guttate hypomelanosis: an electron microscopy study. J Eur Acad Dermatol Venereol. 2015;29(7):1435–8.CrossRefGoogle Scholar
  17. 17.
    Joshipura S, editor. Idiopathic guttate hypopigmentation. 45th national conference of Indian Association of Dermatologists, Venereologists & Leprologists, DERMACON 2017, 12–15 Jan 2017, Kolkata, India.Google Scholar
  18. 18.
    Pagnoni A, Kligman AM, Sadiq I, Stoudemayer T. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol Stockholm. 1999;79:305–10.CrossRefGoogle Scholar
  19. 19.
    Asawanonda P, Sutthipong T, Prejawai N. Pimecrolimus for idiopathic guttate hypomelanosis. J Drugs Dermatol. 2010;9(3):238–9.PubMedGoogle Scholar
  20. 20.
    Ravikiran SP, Sacchidanand S, Leelavathy B. Therapeutic wounding – 88% phenol in idiopathic guttate hypomelanosis. Indian Dermatol Online J. 2014;5(1):14–8.CrossRefGoogle Scholar
  21. 21.
    Rerknimitr P, Disphanurat W, Achariyakul M. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol. 2013;27(4):460–4.CrossRefGoogle Scholar
  22. 22.
    Gupta K, Tripathi S, Kaur M. Evaluation of placental extracts as an adjuvant therapy to phenol in treatment of idiopathic guttate hypomelanosis. J Clin Diagn Res. 2016;10(8):WC01.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Kumarasinghe SP. 3-5 second cryotherapy is effective in idiopathic guttate hypomelanosis. J Dermatol. 2004;31(5):437–9.CrossRefGoogle Scholar
  24. 24.
    Ploysangam T, Dee-Ananlap S, Suvanprakorn P. Treatment of idiopathic guttate hypomelanosis with liquid nitrogen: light and electron microscopic studies. J Am Acad Dermatol. 1990;23(4 Pt 1):681–4.CrossRefGoogle Scholar
  25. 25.
    Hexsel DM. Treatment of idiopathic guttate hypomelanosis by localized superficial dermabrasion. Dermatol Surg. 1999;25(11):917–8.CrossRefGoogle Scholar
  26. 26.
    Shin J, Kim M, Park SH, Oh SH. The effect of fractional carbon dioxide lasers on idiopathic guttate hypomelanosis: a preliminary study. J Eur Acad Dermatol Venereol. 2013;27(2):e243–6.CrossRefGoogle Scholar
  27. 27.
    Rerknimitr P, Chitvanich S, Pongprutthipan M, Panchaprateep R, Asawanonda P. Non-ablative fractional photothermolysis in treatment of idiopathic guttate hypomelanosis. J Eur Acad Dermatol Venereol. 2015;29(11):2238–42.CrossRefGoogle Scholar
  28. 28.
    Gordon JR, Reed KE, Sebastian KR, Ahmed AM. Excimer light treatment for idiopathic guttate hypomelanosis: a pilot study. Dermatol Surg. 2017;43(4):553–7.CrossRefGoogle Scholar
  29. 29.
    Cattano AN. An unusual case of keratosis follicularis. Arch Dermatol. 1968;98(2):168–74.CrossRefGoogle Scholar
  30. 30.
    Berth-Jones J, Hutchinson P. Darier's disease with peri-follicular depigmentation. Br J Dermatol. 1989;120(6):827–30.CrossRefGoogle Scholar
  31. 31.
    Hakuno M, Shimizu H, Akiyama M, Amagai M, Wahl J, Wheelock M, et al. Dissociation of intra-and extracellular domains of desmosomal cadherins and E-cadherin in Hailey–Hailey disease and Darier’s disease. Br J Dermatol. 2000;142(4):702–11.CrossRefGoogle Scholar
  32. 32.
    Goh B, Kumarasinghe S, Ng S. Two Singaporean cases of guttate leucoderma in Darier's disease. Clin Exp Dermatol. 2004;29(3):313–4.CrossRefGoogle Scholar
  33. 33.
    Goh B, Kumarasinghe P, Lee Y. Loss of melanosome transfer accounts for guttate leucoderma in Darier's disease. Pigment Cell Res. 2005;18:48.Google Scholar
  34. 34.
    Terrom M, Dhaille F, Baltazard T, Dadban A, Sevestre H, Lok C, et al. Guttate leukoderma in Darier disease: case report and review. J Eur Acad Dermatol Venereol. 2016;30(12):e205–e9.CrossRefGoogle Scholar
  35. 35.
    Grosshans E, Sengel D, Heid E. White lentiginosis. Annales de dermatologie et de venereologie. 1994;121(1):7–10.Google Scholar
  36. 36.
    Moulinas C, Banea S, De Cambourg G, Bochaton H, Tortel M, Cribier B, et al. A second case of white lentiginosis. Annales de dermatologie et de venereologie. 2015;142(4):281–4.Google Scholar
  37. 37.
    Neri I, Bassi A, Misciali C, Bagni A, Patrizi A. Familial white lentiginosis. British Journal of Dermatology. 2017;177(2):535–7.CrossRefGoogle Scholar
  38. 38.
    Cole LA. Hypopigmentation with punctate keratosis of the palms and soles. Arch Dermatol. 1976;112(7):998–1000.CrossRefGoogle Scholar
  39. 39.
    Moore MM, Orlow SJ, Kamino H, Wang N, Schaffer JV. Cole disease: guttate hypopigmentation and punctate palmoplantar keratoderma. Arch Dermatol. 2009;145(4):495–7.CrossRefGoogle Scholar
  40. 40.
    Schmieder A, Hausser I, Schneider SW, Goerdt S, Peitsch WK. Palmoplantar hyperkeratoses and hypopigmentation. Cole disease. Acta Derm Venereol. 2011;91(6):737–8.CrossRefGoogle Scholar
  41. 41.
    Vignale R, Yusin A, Panuncio A, Abulafia J, Reyno Z, Vaglio A. Cole disease: hypopigmentation with punctate keratosis of the palms and soles. Pediatr Dermatol. 2002;19(4):302–6.CrossRefGoogle Scholar
  42. 42.
    Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev. 2008;29(1):62–75.CrossRefGoogle Scholar
  43. 43.
    Eytan O, Morice-Picard F, Sarig O, Ezzedine K, Isakov O, Li Q, et al. Cole disease results from mutations in ENPP1. Am J Hum Genet. 2013;93(4):752–7.CrossRefGoogle Scholar
  44. 44.
    Wysong A, Sundram U, Benjamin L. Clear-cell papulosis: a rare entity that may be misconstrued pathologically as normal skin. Pediatr Dermatol. 2012;29(2):195–8.CrossRefGoogle Scholar
  45. 45.
    Kuo TT, Chan HL, Hsueh S. Clear cell papulosis of the skin. A new entity with histogenetic implications for cutaneous Paget's disease. Am J Surg Pathol. 1987;11(11):827–34.CrossRefGoogle Scholar
  46. 46.
    Kumarasinghe SPW, Chin GY, Kumarasinghe MP. Clear cell papulosis of the skin: a case report from Singapore. Arch Pathol Lab Med. 2004;128(11):e149–e52.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Kuo T-T, Huang C-L, Chan H-L, Yang L-J, Chen M-J. Clear cell papulosis: report of three cases of a newly recognized disease. J Am Acad Dermatol. 1995;33(2):230–3.CrossRefGoogle Scholar
  48. 48.
    Tseng FW, Kuo TT, Lu PH, Chan HL, Chan MJ, Hui RC. Long-term follow-up study of clear cell papulosis. J Am Acad Dermatol. 2010;63(2):266–73.CrossRefGoogle Scholar
  49. 49.
    Goodfield M, Jones S, Veale D. The ‘connective tissue diseases’. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology, vol. 3. 8th ed. Hoboken: Wiley-Blackwell; 2010. p. 51.112–51.8.Google Scholar
  50. 50.
    Suchonwanit P, Ruangchainikom P, Apibal Y. Eruptive tumors of the follicular infundibulum: an unexpected diagnosis of Hypopigmented macules. Dermatol Ther (Heidelb). 2015;5(3):207–11.CrossRefGoogle Scholar
  51. 51.
    Alomari A, Subtil A, Owen CE, McNiff JM. Solitary and multiple tumors of follicular infundibulum: a review of 168 cases with emphasis on staining patterns and clinical variants. J Cutan Pathol. 2013;40(6):532–7.CrossRefGoogle Scholar
  52. 52.
    Matveev N, Kile M. Pigmentation changes resulting from chronic arsenic exposure. In: Zhai H, Wilhelm K, Maibach H, editors. Marzulli and Maibach’s dermatotoxicology. 7th ed. Boca Raton: CRC Press/Taylor and Francis Group; 2008. p. 873–80.Google Scholar
  53. 53.
    Guifan S, Jiayi L, Luong T, Dianjun S, Liying W. In: Guifan S, editor. Endemic arsenicosis: A clinical diagnostic manual with photo illustrations. UNICEF East Asia and Pacific Regional Office: Bangkok; 2004. 59 p.Google Scholar
  54. 54.
    Northrup H, Krueger DA, Group ITSCC. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Key Points of the Chinese Guidelines for Clinical Diagnostic of arsenicosis. Pediatr Neurol. 2013;49(4):243–54.Google Scholar
  55. 55.
    Jozwiak S, Schwartz RA, Janniger CK, Michałowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37(12):911–7.CrossRefGoogle Scholar
  56. 56.
    Webb D, Carke A, Fyer A, Osborne J. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135(1):1–5.CrossRefGoogle Scholar
  57. 57.
    Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9(2):88–100.CrossRefGoogle Scholar
  58. 58.
    Seibert D, Hong C-H, Takeuchi F, Olsen C, Hathaway O, Moss J, et al. Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences. Ann Intern Med. 2011;154(12):806–13.CrossRefGoogle Scholar
  59. 59.
    Jacks SK, Witman PM. Tuberous sclerosis complex: an update for dermatologists. Pediatr Dermatol. 2015;32(5):563–70.CrossRefGoogle Scholar
  60. 60.
    Marchell RM, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol. 2007;25(3):295–302.CrossRefGoogle Scholar
  61. 61.
    Thomas RH, McKee PH, Black MM. Hypopigmented sarcoidosis. J R Soc Med. 1981;74(12):921–3.CrossRefGoogle Scholar
  62. 62.
    Hall RS, Floro JF, King LE Jr. Hypopigmented lesions in sarcoidosis. J Am Acad Dermatol. 1984;11(6):1163–4.CrossRefGoogle Scholar
  63. 63.
    Tan SK, Sim CS, Goh CL. Hydroquinone-induced exogenous ochronosis in Chinese – two case reports and a review. Int J Dermatol. 2008;47(6):639–40.CrossRefGoogle Scholar
  64. 64.
    Tan SK. Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment. J Eur Acad Dermatol Venereol. 2011;25(7):842–50.CrossRefGoogle Scholar
  65. 65.
    Liu WC, Tey HL, Lee JS, Goh BK. Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site. Singap Med J. 2014;55(1):e1–3.CrossRefGoogle Scholar
  66. 66.
    Simmons BJ, Griffith RD, Bray FN, Falto-Aizpurua LA, Nouri K. Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments. Am J Clin Dermatol. 2015;16(3):205–12.CrossRefGoogle Scholar
  67. 67.
    Arunprasath P, Reji S, Srivenkateswaran K. Vitiligo ponctue. Pigment Int. 2015;2(2):103.CrossRefGoogle Scholar
  68. 68.
    Bieber T, Bussmann C. Atopic Dermatitis. In: Bolognia J, Joseph L, Shaffer J, editors. Dermatology. 1. 3 ed: Elsevier Saunders; 2012. p. 203–17.Google Scholar
  69. 69.
    Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Elsevier Saunders, Philadelphia. Clin Microbiol Rev. 2012;25(1):106–41.Google Scholar
  70. 70.
    Wille G, Mayser P, Thoma W, Monsees T, Baumgart A, Schmitz HJ, et al. Malassezin – a novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg Med Chem. 2001;9(4):955–60.CrossRefGoogle Scholar
  71. 71.
    Kramer HJ, Kessler D, Hipler UC, Irlinger B, Hort W, Bodeker RH, et al. Pityriarubins, novel highly selective inhibitors of respiratory burst from cultures of the yeast Malassezia furfur: comparison with the bisindolylmaleimide arcyriarubin A. Chembiochem. 2005;6(12):2290–7.CrossRefGoogle Scholar
  72. 72.
    Machowinski A, Kramer HJ, Hort W, Mayser P. Pityriacitrin – a potent UV filter produced by Malassezia furfur and its effect on human skin microflora. Mycoses. 2006;49(5):388–92.CrossRefGoogle Scholar
  73. 73.
    Mayser P, Schafer U, Kramer HJ, Irlinger B, Steglich W. Pityriacitrin – an ultraviolet-absorbing indole alkaloid from the yeast Malassezia furfur. Arch Dermatol Res. 2002;294(3):131–4.CrossRefGoogle Scholar
  74. 74.
    Larangeira de Almeida H, Mayser P. Absence of sunburn in lesions of pityriasis versicolor alba. Mycoses. 2006;49(6):516.CrossRefGoogle Scholar
  75. 75.
    Gambichler T, Kramer HJ, Boms S, Skrygan M, Tomi NS, Altmeyer P, et al. Quantification of ultraviolet protective effects of pityriacitrin in humans. Arch Dermatol Res. 2007;299(10):517–20.CrossRefGoogle Scholar
  76. 76.
    Nazzaro-Porro M, Passi S. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol. 1978;71(3):205–8.CrossRefGoogle Scholar
  77. 77.
    Relyveld GN, Menke HE, Westerhof W. Progressive macular hypomelanosis. Am J Clin Dermatol. 2007;8(1):13–9.CrossRefGoogle Scholar
  78. 78.
    Bessis D, Jeziorski É, Rigau V, Pralong P, Pallure V. Bier anaemic spots, cyanosis with urticaria-like eruption (BASCULE) syndrome: a new entity? Br J Dermatol. 2016;175(1):218–20.CrossRefGoogle Scholar
  79. 79.
    Lestringant GG, Masouyé I, Frossard P, Adeghate E, Galadari I. Co-existence of leukoderma with features of Dowling-Degos disease: reticulate acropigmentation of Kitamura spectrum in five unrelated patients. Dermatology. 1997;195(4):337–43.CrossRefGoogle Scholar
  80. 80.
    Lee SJ, Lee HJ, Kim DW, Jun JB, Chung SL, Bae HI. A case of Dowling-Degos disease suggesting an evolutional sequence. J Dermatol. 2000;27(9):591–7.CrossRefGoogle Scholar
  81. 81.
    Sandhu K, Saraswat A, Kanwar A. Dowling–Degos disease with dyschromatosis universalis hereditaria-like pigmentation in a family. J Eur Acad Dermatol Venereol. 2004;18(6):702–4.CrossRefGoogle Scholar
  82. 82.
    Thami G, Jaswal R, Kanwar A, Radotra B, Singh I. Overlap of reticulate acropigmentation of Kitamura, acropigmentation of Dohi and Dowling-Degos disease in four generations. Dermatology. 1998;196(3):350–1.CrossRefGoogle Scholar
  83. 83.
    Nirmal B, Dongre AM, Khopkar US. Dermatoscopic features of hyper and hypopigmented lesions of Dowling-Degos disease. Indian J Dermatol. 2016;61(1):125.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Wu Y-H, Lin Y-C. Generalized Dowling-Degos disease. J Am Acad Dermatol. 2007;57(2):327–34.CrossRefGoogle Scholar
  85. 85.
    Chang MW. Disorders of Hyperpigmentation. In: Bolognia J, Joseph L, Shaffer J, editors. Dermatology. 1. 3 ed. Philadelphia: Elsevier Saunders; 2012. p. 1049–74.Google Scholar
  86. 86.
    Morishima T. A clinical variety of primary localized cutaneous amyloidosis characterized by dyschromia (amyloidosis cutis dyschromica). Jpn J Dermatol Ser B. 1970;80(1):43–52.Google Scholar
  87. 87.
    Ho MS, Ho J, Tan SH. Hypopigmented macular amyloidosis with or without hyperpigmentation. Clin Exp Dermatol. 2009;34(8):e547–51.CrossRefGoogle Scholar
  88. 88.
    Eng AM, Cogan L, Gunnar RM, Blekys I. Familial generalized dyschromic amyloidosis cutis. J Cutan Pathol. 1976;3(2):102–8.CrossRefGoogle Scholar
  89. 89.
    Al Hawsawi K, Al Aboud K, Ramesh V, Al Aboud D. Dyschromatosis universalis hereditaria: report of a case and review of the literature. Pediatr Dermatol. 2002;19(6):523–6.CrossRefGoogle Scholar
  90. 90.
    Pawsey SA, Magnus IA, Ramsay CA, Benson PF, Giannelli F. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Q J Med. 1979;48(190):179–210.PubMedGoogle Scholar
  91. 91.
    Irvine A, Mellerio J. Genetics and Genodermatoses. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of Dermatology. 1. 8 ed. Hoboken, NJ: Wiley-Blackwell; 2010. p. 15.1–.97.Google Scholar
  92. 92.
    Kirnbauer R, Lenz P. Human Papillomaviruses. In: Bolognia J, Joseph L, Shaffer J, editors. Dermatolgy. 2. 3 ed. Philadelphia: Elsevier Saunders; 2012. p. 1303–18.Google Scholar
  93. 93.
    Kim HS, DS Y, Kim JW. White fibrous papulosis of the neck. J Eur Acad Dermatol Venereol. 2007;21(3):419–20.CrossRefGoogle Scholar
  94. 94.
    Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol. 2001;44(2, Part 1):273–81.CrossRefGoogle Scholar
  95. 95.
    Kopf AW, Morrill S, Silberberg I. Broad spectrum of leukoderma acquisitum centrifugum. Arch Dermatol. 1965;92(1):14–35.CrossRefGoogle Scholar
  96. 96.
    Anstey A. Disorders of Skin Colour. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of Dermatology. 3. Hoboken, NJ: Wiley-Blackwell; 2010. p. 58. 49–50.Google Scholar
  97. 97.
    Kazakov D, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18(4):397–415.CrossRefGoogle Scholar
  98. 98.
    Bowers S, Warshaw EM. Pityriasis Lichenoides and its subtypes. J Am Acad Dermatol. 2006;55(4):557–72.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nisansala Mahenthi Nagodavithana
    • 1
  • Prasad Kumarasinghe
    • 2
  1. 1.Department of DermatologySir Charles Gairdner HospitalNedlandsAustralia
  2. 2.Department of DermatologyFiona Stanley Hospital and University of Western AustraliaPerthAustralia

Personalised recommendations